Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

83.58

+13.93 (20.00%)

At close: Aug 4, 2026

14.68% (1Y)

Market Cap	10.17B +14.7%
Revenue (ttm)	727.69M +18.0%
Net Income	157.25M +56.0%
EPS	1.29 +61.7%
Shares Out	121.64M
PE Ratio	64.65
Forward PE	n/a
Dividend	5.20 (7.47%)
Ex-Dividend Date	May 15, 2026

Volume	10,254,640
Open	70.01
Previous Close	69.65
Day's Range	70.01 - 83.58
52-Week Range	58.05 - 85.00
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Sino Biological,Inc.

Sino Biological,Inc. engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, in... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,069

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.

Financial Statements